Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
about
Volatile Organic Compound Gamma-Butyrolactone Released upon Herpes Simplex Virus Type -1 Acute Infection Modulated Membrane Potential and Repressed Viral Infection in Human Neuron-Like CellsSeeking genetic signature of radiosensitivity--a novel method for data analysis in case of small sample sizes.Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot studyThe monoamine oxidase A gene promoter repeat and prostate cancer riskSubpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways.Serotoninergic and Circadian Systems: Driving Mammary Gland Development and Function.Fluoxetine protects against methamphetamine‑induced lung inflammation by suppressing oxidative stress through the SERT/p38 MAPK/Nrf2 pathway in rats.Effects and related mechanisms of serotonin on malignant biological behavior of hepatocellular carcinoma via regulation of YapEnhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model.Pharmacological characterization of N1-(2-methoxyphenyl)-N4-hexylpiperazine as a multi-target antagonist of α1A/α1D-adrenoceptors and 5-HT1A receptors that blocks prostate contraction and cell growth.Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.
P2860
Q28553599-CEFB8358-07BB-433B-98E5-75875C01FD35Q30839885-26A4C724-5FAA-491F-B584-1848D56C9843Q36041671-7975B910-6545-41AD-A7DA-02AFBF0553F2Q36495925-79C90A05-1FA5-46AC-9352-AA9FE1B7BCB1Q36814160-4842E092-C389-4D74-944E-C52BC6053531Q37095999-7337FBA1-000E-4C8A-8471-6CC581B598A0Q37720119-D30AB684-A723-4CEF-9F66-AD05BDF58751Q38679866-70575202-5361-409A-A8CC-EFE24B5AB704Q39037597-2021B769-084B-46F6-A439-E921AB8891CBQ39064824-7BDE33FA-902C-4DF5-B56B-261D6C9D1137Q40262420-8E09C341-1EDC-4C9B-AAC1-16EFDFCE564D
P2860
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Serotonin activates MAP kinase ...... in prostate cancer cell lines.
@en
Serotonin activates MAP kinase ...... in prostate cancer cell lines.
@nl
type
label
Serotonin activates MAP kinase ...... in prostate cancer cell lines.
@en
Serotonin activates MAP kinase ...... in prostate cancer cell lines.
@nl
prefLabel
Serotonin activates MAP kinase ...... in prostate cancer cell lines.
@en
Serotonin activates MAP kinase ...... in prostate cancer cell lines.
@nl
P2093
P1433
P1476
Serotonin activates MAP kinase ...... in prostate cancer cell lines.
@en
P2093
Anders Bjartell
Kristin Austild-Taskén
Martina Tinzl
Nishtman Dizeyi
Per-Anders Abrahamsson
Petter Hedlund
P304
P356
10.1016/J.UROLONC.2009.09.013
P577
2009-11-19T00:00:00Z